Show simple item record

dc.creatorSachdeva, R
dc.creatorDarbinian, N
dc.creatorKhalili, K
dc.creatorAmini, S
dc.creatorGonzalez, D
dc.creatorDjeghader, A
dc.creatorChabriére, E
dc.creatorSuh, A
dc.creatorScott, K
dc.creatorSimm, M
dc.date.accessioned2021-01-31T18:54:53Z
dc.date.available2021-01-31T18:54:53Z
dc.date.issued2013-08-06
dc.identifier.issn1932-6203
dc.identifier.issn1932-6203
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/5367
dc.identifier.other23936341 (pubmed)
dc.identifier.urihttp://hdl.handle.net/20.500.12613/5385
dc.description.abstractIndependent research groups reported that DING protein homologues isolated from bacterial, plant and human cells demonstrate the anti-HIV-1 activity. This might indicate that diverse organisms utilize a DING-mediated broad-range protective innate immunity response to pathogen invasion, and that this mechanism is effective also against HIV-1. We performed structural analyses and evaluated the anti-HIV-1 activity for four DING protein homologues isolated from different species. Our data show that bacterial PfluDING, plant p38SJ (pDING), human phosphate binding protein (HPBP) and human extracellular DING from CD4 T cells (X-DING-CD4) share high degrees of structure and sequence homology. According to earlier reports on the anti-HIV-1 activity of pDING and X-DING-CD4, other members of this protein family from bacteria and humans were able to block transcription of HIV-1 and replication of virus in cell based assays. The efficacy studies for DING-mediated HIV-1 LTR and HIV-1 replication blocking activity showed that the LTR transcription inhibitory concentration 50 (IC50) values ranged from 0.052-0.449 ng/ml; and the HIV-1 replication IC50 values ranged from 0.075-0.311 ng/ml. Treatment of cells with DING protein alters the interaction between p65-NF-κB and HIV-1 LTR. Our data suggest that DING proteins may be part of an innate immunity defense against pathogen invasion; the conserved structure and activity makes them appealing candidates for development of a novel therapeutics targeting HIV-1 transcription. © 2013 Sachdeva et al.
dc.format.extente69623-e69623
dc.language.isoen
dc.relation.haspartPLoS ONE
dc.relation.isreferencedbyPublic Library of Science (PLoS)
dc.rightsCC BY
dc.subjectAmino Acid Sequence
dc.subjectAnti-HIV Agents
dc.subjectCell Line, Tumor
dc.subjectConserved Sequence
dc.subjectHIV-1
dc.subjectHumans
dc.subjectHypericum
dc.subjectInhibitory Concentration 50
dc.subjectModels, Molecular
dc.subjectMolecular Sequence Data
dc.subjectNF-kappa B p50 Subunit
dc.subjectPhylogeny
dc.subjectPolycomb Repressive Complex 1
dc.subjectPromoter Regions, Genetic
dc.subjectProtein Multimerization
dc.subjectProtein Structure, Quaternary
dc.subjectPseudomonas fluorescens
dc.subjectSequence Homology, Amino Acid
dc.subjectTerminal Repeat Sequences
dc.subjectTranscription Factor RelA
dc.subjectTranscription, Genetic
dc.subjectVirus Replication
dc.titleDING Proteins from Phylogenetically Different Species Share High Degrees of Sequence and Structure Homology and Block Transcription of HIV-1 LTR Promoter
dc.typeArticle
dc.type.genreJournal Article
dc.relation.doi10.1371/journal.pone.0069623
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.date.updated2021-01-31T18:54:49Z
refterms.dateFOA2021-01-31T18:54:53Z


Files in this item

Thumbnail
Name:
DING proteins from phylogenetically ...
Size:
1.428Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record